NEXT Financial Holdings’s Oncolytics Biotech ONCY Stock Holding History

NEXT Financial Holdings’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$4K	Buy	+1,893	New	+$3.84K	﹤0.01%	1318

Other funds holding ONCY

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

NEXT Financial Holdings's ONCY Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Oncolytics Biotech (ONCY) in Q1 2019: 1,893 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #1318 among its holdings.

22 funds tracked by Wall St. Rank hold ONCY as of Q1 2019.

NEXT Financial Holdings held 1,893 shares of Oncolytics Biotech worth $4K as of Q1 2019.
Oncolytics Biotech was a new NEXT Financial Holdings position in Q1 2019.
Oncolytics Biotech made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #1318 holding.
22 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.